About
Jafron Biomedical, founded in 1989 and publicly listed on the ChiNext board, is a global leader in blood purification technology. The company specializes in hemoadsorption, developing advanced medical devices and biomaterials for clinical treatments like hemodialysis and hemoperfusion. With a market value of around $7 billion, Jafron operates from its headquarters in Zhuhai, China, and has a significant presence with 183 offices in China and five global service centers. The company offers a range of blood purification products, including the HA series disposable hemoperfusion cartridge, which is used in over 8,000 hospitals across more than 90 countries. Jafron's therapies are designed to improve patient outcomes in critical care and chronic disease management. The company is recognized for its commitment to innovation and quality, holding multiple certifications and awards, and collaborating with healthcare professionals worldwide to enhance patient care.
Technologies
Keywords
Company Information
-
Employees 2800
-
Founded 1989
-
Annual Revenue $323221000
Location
Zhuhai, China, 519085